Literature DB >> 600163

Complications of intravenous therapy: reduction by buffering of intravenous fluid preparation.

O Eremin, V Marshall.   

Abstract

Local complicationn of intravenous infusions have become a common cause of morbidity in hospitals. Two consecutive groups of patients were studied: the patients in the first group had received standard non-buffered intravenous fluid preparations with pH from 3.6 to 6.0; the second group of patients received fluids which were buffered to a neutral pH. The incidence of local complications in the first group was high (58%), with phlebitis being the most common complication which occurred in 43% of patients. The addition of a buffer to the fluids just before the infusion reduced the incidence of all complications in the second group of patients to 28%, and that of phlebitis to 19%. It will be shown that the complications can be significantly reduced by buffering the infusion fluids.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 600163     DOI: 10.5694/j.1326-5377.1977.tb114619.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

Review 1.  Potential for extending survival of peripheral intravenous infusions.

Authors:  J F Hecker
Journal:  BMJ       Date:  1992-03-07

2.  Studies in phlebitis: detection and quantitation using a thermographic camera.

Authors:  G H Ward; P E Nolan; M Chawla; S H Yalkowsky
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

3.  Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients.

Authors:  Yoichiro Yoshida; Seiichiro Hoshino; Naoya Aisu; Masayasu Naito; Syu Tanimura; Ai Mogi; Toshihiro Tanaka; Keiji Hirata; Kazuo Tamura; Yuichi Yamashita
Journal:  Int J Clin Oncol       Date:  2014-05-10       Impact factor: 3.402

4.  Intersubject and dose-related variability after intravenous administration of erythromycin.

Authors:  K L Austin; L E Mather; C R Philpot; P J McDonald
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

5.  Survival of intravenous chemotherapy infusion sites.

Authors:  J F Hecker
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.